Rubella seroprevalence among mothers and incidence of congenital rubella three years after rubella vaccine introduction in Vietnam

References

• World Health Organization. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011; 86:301–16.
   PubMedGoogle Scholar
• Plotkin SA. Rubella eradication. Vaccine. 2001;19:3311–19. doi:10.1016/S0264-410X(01)00073-1.
   PubMed Web of Science ®Google Scholar
• Miyakawa M, Yoshino H, Yoshida LM, Vynnycky E, Motomura H, Tho LH, Thiem VD, Ariyoshi K, Anh DD, Moriuchi H. Seroprevalence of rubella in the cord blood of pregnant women and congenital rubella incidence in Nha Trang, Vietnam. Vaccine. 2014;32:1192–98. doi:10.1016/j.vaccine.2013.08.076.
   PubMed Web of Science ®Google Scholar
• Toda K, Reef S, Tsuruoka M, Iijima M, Dang TH, Duong TH, Nguyen VC, Nguyen TH. Congenital rubella syndrome (CRS) in Vietnam 2011-2012-CRS epidemic after rubella epidemic in 2010-2011. Vaccine. 2015;33:3673–77. doi:10.1016/j.vaccine.2015.06.035.
   PubMed Web of Science ®Google Scholar
• Vynnycky E, Adams EJ, Cutts FT, Reef SE, Navar AM, Simons E, Yoshida LM, Brown DWJ, Jackson C, Strebel PM, et al. Using seroprevalence and immunisation coverage data to estimate the global burden of Congenital Rubella Syndrome, 1996-2010: a systematic review. PLoS One. 2016;11:e0149160. doi:10.1371/journal.pone.0149160.
   PubMed Web of Science ®Google Scholar
• Vynnycky E, Yoshida LM, Thanh Huyen DT, Trung ND, Toda K, Van Cuong N, Hong DT, Ariyoshi K, Miyakawa M, Moriuchi H, et al. Modeling the impact of rubella vaccination in Vietnam. Hum Vaccin Immunother. 2016;12:150–58. doi:10.1080/21645515.2015.1060380.
   PubMed Web of Science ®Google Scholar
• Ministry of health, Vietnam; 2021 Feb 1 [accessed 2021 Feb 1]. https://www.moh.gov.vn/en_US/web/ministry-of-health .
   Google Scholar
• WHO vaccine-preventable disease: monitoring system. 2020 global summary; 2020 July 15 [accessed 2021 Feb 1]. https://apps.who.int/immunization_monitoring/globalsummary .
   Google Scholar
• Skendzel LP. Rubella Immunity: defining the level of protective antibody. Am J Clin Pathol. 1996;106:170–74. doi:10.1093/ajcp/106.2.170.
   PubMed Web of Science ®Google Scholar
• Best JM, Reef S. The immunological basis for immunisation series. Module 11: rubella. In: Immunization, Vacccines and Biologicals. Geneva (Switzerland): World Health Organization; 2008.
   Google Scholar
• Okamoto K, Fujii K, Komase K. Development of a novel TaqMan real-time PCR assay for detecting rubella virus RNA. J Virol Methods. 2010;168:267–71. doi:10.1016/j.jviromet.2010.05.016.
   PubMed Web of Science ®Google Scholar
• Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet. 2015;385:2297–307. doi:10.1016/S0140-6736(14)60539-0.
   PubMed Web of Science ®Google Scholar
• Zahraei SM, Mokhtari-Azad T, Sabouri A, Khazaei S, Karami M. Sero-epidemiological evaluation of rubella immunity among pre-marriage women in Iran. Hum Vaccin Immunother. 2019;15:2117–20. doi:10.1080/21645515.2018.1504527.
   PubMed Web of Science ®Google Scholar
• Plewik D, Tokarska-Rodak M, Paszkiewicz J, Szepeluk A. Seroprevalence of rubella and cytomegalia in young women from biała podlaska district. Pol J Microbiol. 2017;66:543–45. doi:10.5604/01.3001.0010.7103.
   PubMed Web of Science ®Google Scholar
• Costa GB, De Oliveira MC, Gadelha SR, Albuquerque GR, Teixeira M, Raiol MRDS, Sousa SMB, Marin LJ. Infectious diseases during pregnancy in Brazil: seroprevalence and risk factors. J Infect Dev Ctries. 2018;12:657–65. doi:10.3855/JIDC.9492.
   PubMed Web of Science ®Google Scholar
• Palihawadana P, Wickremasinghe AR, Perera J. Seroprevalence of rubella antibodies among pregnant females in Sri Lanka. Southeast Asian J Trop Med Public Health. 2003;34:398–404.
   PubMedGoogle Scholar
• Liu F, Zhang S, Liu J, Wang Q, Shen H, Zhang Y, Liu M. Sociodemographic and economic characteristics of susceptibility to rubella among women preparing for pregnancy in rural China. Int J Infect Dis. 2017;62:112–18. doi:10.1016/j.ijid.2017.07.013.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, Acharya G. Rubella virus immunisation status in preconception period among Chinese women of reproductive age: a nation-wide, cross-sectional study. Vaccine. 2017;35:3076–81. doi:10.1016/j.vaccine.2017.04.044.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rubella vaccines: WHO position paper—Recommendations. Vaccine. 2011;29:8767–68. doi:10.1016/j.vaccine.2011.08.061.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rubella vaccines: WHO position paper – July 2020. Wkly Epidemiol Rec. 2020; 95:306–24.
   Google Scholar
• Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL. Control of rubella and congentital rubella syndrome (CRS) in developing countries, part 2: vaccination against rubella. Bull World Health Organ. 1997;75:69–80.
   PubMed Web of Science ®Google Scholar
• Mongua-Rodriguez N, Díaz-Ortega JL, García-García L, Piña-Pozas M, Ferreira-Guerrero E, Delgado-Sánchez G, Ferreyra-Reyes L, Cruz-Hervert LP, Baez-Saldaña R, Campos-Montero R. A systematic review of rubella vaccination strategies implemented in the Americas: impact on the incidence and seroprevalence rates of rubella and congenital rubella syndrome. Vaccine. 2013;31:2145–51. doi:10.1016/j.vaccine.2013.02.047.
   PubMed Web of Science ®Google Scholar
• Herrmann KL, Halstead SB, Brandling Bennett AD, Witte JJ, Wiebenga NH, Eddins DL. Rubella immunization: persistence of antibody four years after a large-scale field trial. J Am Med Assoc. 1976;235:2201–04. doi:10.1001/jama.1976.03260460021015.
   Web of Science ®Google Scholar
• Castillo-Solórzano C, Carrasco P, Tambini G, Reef S, Brana M, De Quadros CA. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis. 2003;187:S146–S152. doi:10.1086/368034.
   PubMed Web of Science ®Google Scholar
• Man C, Umido V, Bakir J, Caparelli M, Copiz A, Castillo C, Gentile A. Evaluation of the immunisation impact on the epidemiology of rubella and congenital rubella syndrome in Argentina. Rev Hosp Niños (B Aires). 2005;47:205–10.
   Google Scholar
• Lanzieri TM, Pinto D, Prevots DR. Impact of rubella vaccination strategy on the occurrence of congenital rubella syndrome. J Pediatr (Rio J). 2007;83:415–21. doi:10.2223/JPED.1692.
   PubMed Web of Science ®Google Scholar
• Menegolla IA, Bercini MA, Schermann MT, Nunes ZMA, Segatto TC, Siqueira MM, Flannery B. Outbreak of rubella after mass vaccination of children and adult women: challenges for rubella elimination strategies. Rev Panam Salud Publica. 2011;29:243–51. doi:10.1590/S1020-49892011000400005.
   PubMed Web of Science ®Google Scholar
• Orenstein WA, Herrmann KL, Holmgreen P, Bernier R, Bart KJ, Eddins DL, Fiumara NJ. Prevalence of rubella antibodies in Massachusetts school children. Am J Epidemiol. 1986;124:290–98. doi:10.1093/oxfordjournals.aje.a114387.
   PubMed Web of Science ®Google Scholar
• De Los Angeles Ribas M, Galindo M, Torres G, Valcarsel M, Cancio R, Mg G, Rosario D, Resik S, Rodriguez C, Garcia D, et al. Role of the virology diagnosis laboratory in the surveillance of rubella virus: cuba 1988/2000. Vaccine. 2004;22:4287–90. doi:10.1016/j.vaccine.2004.04.023.
   PubMed Web of Science ®Google Scholar
• Díaz-Ortega JL, Meneses-Reyes CD, Palacios-Martínez M. Incidence and transmission patterns of rubella in Mexico. Salud Publica Mex. 2007;49:337–44. doi:10.1590/S0036-36342007000500004.
   PubMed Web of Science ®Google Scholar
• Jiménez G, Ávila-Aguero ML, Morice A, Gutiérrez H, Soriano A, Badilla X, Reef S, Castillo-Solórzano C. Estimating the burden of congenital rubella syndrome in Costa Rica, 1996-2001. Pediatr Infect Dis J. 2007;26:382–86. doi:10.1097/01.inf.0000260000.84792.9e.
   PubMed Web of Science ®Google Scholar
• Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P. Screening for potential susceptibility to rubella in an antenatal population: a multivariate analysis. J Med Virol. 2017;89:1532–38. doi:10.1002/jmv.24818.
   PubMed Web of Science ®Google Scholar
• Dayan GH, Panero MS, Urquiza A, Molina M, Prieto S, Del Carmen Perego M, Scagliotti G, Galimberti D, Carroli G, Wolff C, et al. Rubella and measles seroprevalence among women of child-bearing age, Argentina, 2002. Epidemiol Infect. 2005;133:861–69. doi:10.1017/S0950268805004437.
   PubMed Web of Science ®Google Scholar
• Pegha Moukandja I, Ngoungou EB, Lemamy GJ, Bisvigou U, Gessain A, Toure Ndouo FS, Kazanji M, Lekana-Douki JB. Non-malarial infectious diseases of antenatal care in pregnant women in Franceville, Gabon. BMC Pregnancy Childbirth. 2017;17:185. doi:10.1186/s12884-017-1362-0.
   PubMed Web of Science ®Google Scholar
• Muliyil DE, Singh P, Jois SK, Otiv S, Suri V, Varma V, Abraham AM, Raut C, Gupta M, Singh MP, et al. Sero-prevalence of rubella among pregnant women in India, 2017. Vaccine. 2018;36:7909–12. doi:10.1016/j.vaccine.2018.11.013.
   PubMed Web of Science ®Google Scholar
• Sasmaz T, Kurt AO, Ozturk C, Bugdayci R, Oner S. Rubella seroprevalence in women in the reproductive period, Mersin, Turkey. Vaccine. 2007;25:912–17. doi:10.1016/j.vaccine.2006.09.033.
   PubMed Web of Science ®Google Scholar
• Gilbert NL, Rotondo J, Shapiro J, Sherrard L, Fraser WD, Ward BJ. Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008-2011. Vaccine. 2017;35:3050–55. doi:10.1016/j.vaccine.2017.04.057.
   PubMed Web of Science ®Google Scholar
• Lao TT, Sahota DS, Law LW, Leung TY. Maternal rubella immunity status and pre-eclampsia. Am J Reprod Immunol. 2017;78:e12677. doi:10.1111/aji.12677.
   Web of Science ®Google Scholar
• Tamirat B, Hussen S, Shimelis T. Rubella virus infection and associated factors among pregnant women attending the antenatal care clinics of public hospitals in Hawassa City, Southern Ethiopia: a cross-sectional study. BMJ Open. 2017;7:e016824. doi:10.1136/bmjopen-2017-016824.
   PubMed Web of Science ®Google Scholar